Actively Recruiting

Phase 2
Age: 1Month - 28Weeks
All Genders
NCT06270199

Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.

Led by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Updated on 2025-03-17

75

Participants Needed

7

Research Sites

150 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Bronchopulmonary dysplasia (BPD) is a disease that affects preterm newborn patients, preventing their lungs from developing properly. Allogeneic fetal stem mesenchymal cells from umbilical cord could reduce the prevalence of BPD in this patients.

CONDITIONS

Official Title

Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.

Who Can Participate

Age: 1Month - 28Weeks
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Alive newborns weighing 64 1250 grams
  • Gestational age of 28 weeks or less
  • On mechanical ventilation with a fraction of inspired oxygen (FiO2) of 0.3 or higher between days 5 and 14 of life
  • No immediate extubation expected
Not Eligible

You will not qualify if you...

  • Presence of other congenital pathologies affecting lung, kidney, or heart function
  • Active pulmonary hemorrhage or severe pulmonary hypoplasia
  • Refractory hemodynamic instability
  • Severe neurological damage (HIV grade III or higher)
  • Major surgery within 72 hours prior to inclusion
  • Necrotising enterocolitis grade II or higher
  • Child of a mother with HIV

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Hospital Quironsalud Madrid

Pozuelo de Alarcón, Madrid, Spain, 28223

Actively Recruiting

2

Complejo Hospitalario La Coruña

A Coruña, Spain

Actively Recruiting

3

Hospital Clínico San Carlos

Madrid, Spain

Actively Recruiting

4

Hospital Universitario La Paz

Madrid, Spain

Actively Recruiting

5

Hospital Universitario Carlos Haya

Málaga, Spain

Actively Recruiting

6

Hospital Vírgen del Rocío

Seville, Spain

Actively Recruiting

7

Hospital Universitario y Politécnico La Fe

Valencia, Spain

Actively Recruiting

Loading map...

Research Team

M

María Jesús del Cerro, PhD

CONTACT

M

María Álvarez, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here